These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34974973)

  • 21. Presumptive brain influx of large neutral amino acids and the effect of phenylalanine supplementation in patients with Tyrosinemia type 1.
    van Ginkel WG; van Vliet D; Burgerhof JGM; de Blaauw P; Rubio Gozalbo ME; Heiner-Fokkema MR; van Spronsen FJ
    PLoS One; 2017; 12(9):e0185342. PubMed ID: 28949985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation.
    Yano S; Moseley K; Azen C
    J Pediatr; 2014 Jul; 165(1):184-189.e1. PubMed ID: 24857519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implication for maple syrup urine disease and phenylketonuria.
    Zielke HR; Zielke CL; Baab PJ; Collins RM
    Neurochem Int; 2002 Apr; 40(4):347-54. PubMed ID: 11792465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
    Sawin EA; Murali SG; Ney DM
    Mol Genet Metab; 2014 Apr; 111(4):452-61. PubMed ID: 24560888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dietary mixtures of amino acids on fetal growth and maternal and fetal amino acid pools in experimental maternal phenylketonuria.
    Austic RE; Su CL; Strupp BJ; Levitsky DA
    Am J Clin Nutr; 1999 Apr; 69(4):687-96. PubMed ID: 10197570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients.
    Kumru B; Ozturk Hismi B; Kaplan DS; Celik H
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):269-274. PubMed ID: 30835252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
    Moats RA; Moseley KD; Koch R; Nelson M
    Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.
    Pietz J; Kreis R; Rupp A; Mayatepek E; Rating D; Boesch C; Bremer HJ
    J Clin Invest; 1999 Apr; 103(8):1169-78. PubMed ID: 10207169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large neutral amino acid status in association with P:T ratio and diet in adult and pediatric patients with phenylketonuria.
    Douglas TD; Nucci AM; Berry AM; Henes ST; Singh RH
    JIMD Rep; 2019 Nov; 50(1):50-59. PubMed ID: 31741827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria.
    Scala I; Concolino D; Nastasi A; Esposito G; Crisci D; Sestito S; Ferraro S; Albano L; Ruoppolo M; Parenti G; Strisciuglio P
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicompartment analysis of protein-restricted phenylketonuric mice reveals amino acid imbalances in brain.
    Vogel KR; Arning E; Bottiglieri T; Gibson KM
    J Inherit Metab Dis; 2017 Mar; 40(2):227-235. PubMed ID: 27761676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria.
    Burlina AP; Cazzorla C; Massa P; Loro C; Gueraldi D; Burlina AB
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32674279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.
    Winn SR; Scherer T; Thöny B; Ying M; Martinez A; Weber S; Raber J; Harding CO
    Mol Genet Metab; 2018 Jan; 123(1):6-20. PubMed ID: 29331172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine.
    Matalon R; Michals-Matalon K; Bhatia G; Burlina AB; Burlina AP; Braga C; Fiori L; Giovannini M; Grechanina E; Novikov P; Grady J; Tyring SK; Guttler F
    J Inherit Metab Dis; 2007 Apr; 30(2):153-8. PubMed ID: 17334706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
    Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
    PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of high-protein meal plus aspartame ingestion on plasma phenylalanine concentrations in obligate heterozygotes for phenylketonuria.
    Curtius HC; Endres W; Blau N
    Metabolism; 1994 Apr; 43(4):413-6. PubMed ID: 8159095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.
    Solverson P; Murali SG; Brinkman AS; Nelson DW; Clayton MK; Yen CL; Ney DM
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E885-95. PubMed ID: 22297302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large neutral amino acids in daily practice.
    Ahring KK
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S187-90. PubMed ID: 20300852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice.
    van Ginkel WG; van Vliet D; van der Goot E; Faassen MHJR; Vogel A; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31623189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lowering brain phenylalanine levels by giving other large neutral amino acids. A new experimental therapeutic approach to phenylketonuria.
    Andersen AE; Avins L
    Arch Neurol; 1976 Oct; 33(10):684-6. PubMed ID: 987768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.